S&P 500   4,226.05 (-1.45%)
DOW   32,990.44 (-1.32%)
QQQ   354.94 (-1.75%)
AAPL   171.80 (-1.12%)
MSFT   312.49 (-2.89%)
META   300.05 (-2.21%)
GOOGL   132.65 (-1.13%)
AMZN   124.89 (-3.53%)
TSLA   247.67 (-1.56%)
NVDA   436.58 (-2.51%)
NIO   8.68 (-1.25%)
BABA   84.50 (-2.35%)
AMD   100.04 (-3.13%)
T   14.70 (+0.20%)
F   12.04 (-2.19%)
MU   68.05 (+0.13%)
CGC   0.69 (-5.90%)
GE   107.68 (-1.02%)
DIS   79.76 (-2.34%)
AMC   8.06 (-1.10%)
PFE   33.99 (+0.15%)
PYPL   57.52 (-1.78%)
NFLX   375.76 (-1.20%)
S&P 500   4,226.05 (-1.45%)
DOW   32,990.44 (-1.32%)
QQQ   354.94 (-1.75%)
AAPL   171.80 (-1.12%)
MSFT   312.49 (-2.89%)
META   300.05 (-2.21%)
GOOGL   132.65 (-1.13%)
AMZN   124.89 (-3.53%)
TSLA   247.67 (-1.56%)
NVDA   436.58 (-2.51%)
NIO   8.68 (-1.25%)
BABA   84.50 (-2.35%)
AMD   100.04 (-3.13%)
T   14.70 (+0.20%)
F   12.04 (-2.19%)
MU   68.05 (+0.13%)
CGC   0.69 (-5.90%)
GE   107.68 (-1.02%)
DIS   79.76 (-2.34%)
AMC   8.06 (-1.10%)
PFE   33.99 (+0.15%)
PYPL   57.52 (-1.78%)
NFLX   375.76 (-1.20%)
S&P 500   4,226.05 (-1.45%)
DOW   32,990.44 (-1.32%)
QQQ   354.94 (-1.75%)
AAPL   171.80 (-1.12%)
MSFT   312.49 (-2.89%)
META   300.05 (-2.21%)
GOOGL   132.65 (-1.13%)
AMZN   124.89 (-3.53%)
TSLA   247.67 (-1.56%)
NVDA   436.58 (-2.51%)
NIO   8.68 (-1.25%)
BABA   84.50 (-2.35%)
AMD   100.04 (-3.13%)
T   14.70 (+0.20%)
F   12.04 (-2.19%)
MU   68.05 (+0.13%)
CGC   0.69 (-5.90%)
GE   107.68 (-1.02%)
DIS   79.76 (-2.34%)
AMC   8.06 (-1.10%)
PFE   33.99 (+0.15%)
PYPL   57.52 (-1.78%)
NFLX   375.76 (-1.20%)
S&P 500   4,226.05 (-1.45%)
DOW   32,990.44 (-1.32%)
QQQ   354.94 (-1.75%)
AAPL   171.80 (-1.12%)
MSFT   312.49 (-2.89%)
META   300.05 (-2.21%)
GOOGL   132.65 (-1.13%)
AMZN   124.89 (-3.53%)
TSLA   247.67 (-1.56%)
NVDA   436.58 (-2.51%)
NIO   8.68 (-1.25%)
BABA   84.50 (-2.35%)
AMD   100.04 (-3.13%)
T   14.70 (+0.20%)
F   12.04 (-2.19%)
MU   68.05 (+0.13%)
CGC   0.69 (-5.90%)
GE   107.68 (-1.02%)
DIS   79.76 (-2.34%)
AMC   8.06 (-1.10%)
PFE   33.99 (+0.15%)
PYPL   57.52 (-1.78%)
NFLX   375.76 (-1.20%)
OTCMKTS:PURE

PURE Bioscience (PURE) Stock Forecast, Price & News

$0.11
0.00 (0.00%)
(As of 10/2/2023 ET)
Compare
Today's Range
$0.11
▼
$0.11
50-Day Range
$0.08
▼
$0.13
52-Week Range
$0.07
▼
$0.20
Volume
181 shs
Average Volume
31,467 shs
Market Capitalization
$11.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort Interest

PURE stock logo

About PURE Bioscience (OTCMKTS:PURE) Stock

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.

PURE Price History

PURE Stock News Headlines

September 26, 2023 | americanbankingnews.com
PURE Bioscience (OTCMKTS:PURE) Stock Crosses Above 200 Day Moving Average of $0.11
September 20, 2023 | bizjournals.com
Layoffs hit Morrisville firm as it scales back operations
October 3, 2023 | Behind the Markets (Ad)
[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"
The Washington Post Reports it's: "A revolution in warfare." The Sunday Times Reports it's: "a revolutionary power." Early investors can reap 5,633% gains as England, Germany, Japan and Australia rush to sign contracts. Get the name of the stock here >>>
September 2, 2023 | msn.com
Coffee, dolphins & other favorite things that might not exist in 30 years
September 2, 2023 | msn.com
Saavy Naturals: What Happened To The Brand After Shark Tank?
August 30, 2023 | finance.yahoo.com
WILLOW ANNOUNCES FILING OF PATENT APPLICATION FOR PROCESS TO PRODUCE CORTICOSTEROIDS AT SIGNFICANTLY REDUCED COST
August 19, 2023 | msn.com
The Common Food Processing Step That's Detrimental To Our Health
August 8, 2023 | finance.yahoo.com
WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS
October 3, 2023 | Behind the Markets (Ad)
[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"
The Washington Post Reports it's: "A revolution in warfare." The Sunday Times Reports it's: "a revolutionary power." Early investors can reap 5,633% gains as England, Germany, Japan and Australia rush to sign contracts. Get the name of the stock here >>>
August 3, 2023 | bizjournals.com
Most Influential Business Women 2023: Gabriela Ramirez-Arellano helps entrepreneurs achieve their dreams
August 2, 2023 | finance.yahoo.com
WILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON AUGUST 9
July 29, 2023 | finance.yahoo.com
PURE - PURE Bioscience, Inc.
June 16, 2023 | finance.yahoo.com
Vinamilk forms strategic partnerships with top global companies and receives Purity Award for children's milk powder
June 16, 2023 | benzinga.com
PURE Bioscience Stock (OTC:PURE), Dividends
June 14, 2023 | msn.com
PURE Bioscience GAAP EPS of -$0.01, revenue of $0.41M
June 14, 2023 | finance.yahoo.com
PURE Bioscience Reports Fiscal 2023 Third Quarter And Nine-Month Financial Results
June 14, 2023 | markets.businessinsider.com
Why Is NightHawk Biosciences (NHWK) Stock Up 26% Today?
June 13, 2023 | yahoo.com
World's most painful ant sting targets nerves in the same way scorpion venom does
June 7, 2023 | finance.yahoo.com
WILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON JUNE 14
June 2, 2023 | msn.com
Terran Biosciences Seals Deal With France's Pierre Fabre Pharmaceutical
June 2, 2023 | markets.businessinsider.com
Terran Biosciences announces exclusive licensing deal with Pierre Fabre for idazoxan; Terran completes key development milestones
May 16, 2023 | marketwatch.com
Rosiglitazone Maleate Market | Worldwide Industry Trends 2023-2030
May 12, 2023 | marketwatch.com
Silver-based Antimicrobial Agent Market Size and Research Overview 2023-2030
May 12, 2023 | benzinga.com
Terran Biosciences' Four Patent Applications Cover Improved Versions Of Classic Empathogens
May 8, 2023 | marketwatch.com
Vedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease Week
May 8, 2023 | marketwatch.com
Silver-based Antimicrobial Agents Market Size 2023-2031 Industrial Regions by Absolute Reports | with [102 Pages]
May 2, 2023 | marketwatch.com
Antiseptics & Disinfectants Market Trends and Analysis: Exploring Future Growth Potential & its projected CAGR of 6.5% from 2023-2030
See More Headlines
Receive PURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PURE Bioscience and its competitors with MarketBeat's FREE daily newsletter.

PURE Company Calendar

Last Earnings
3/12/2020
Today
10/03/2023
Next Earnings (Estimated)
10/26/2023
Fiscal Year End
7/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Miscellaneous chemical products
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:PURE
CUSIP
N/A
CIK
1006028
Web
www.purebio.com
Phone
(619) 596-8600
Fax
619-596-8790
Employees
15
Year Founded
1992

Profitability

EPS (Most Recent Fiscal Year)
($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,490,000.00
Net Margins
-247.89%
Pretax Margin
-247.89%
Return on Equity
-151.03%
Return on Assets
-123.25%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.16
Quick Ratio
1.90

Sales & Book Value

Annual Sales
$1.81 million
Price / Sales
6.57
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.04 per share
Price / Book
2.66

Miscellaneous

Outstanding Shares
111,860,000
Free Float
64,407,000
Market Cap
$11.89 million
Optionable
Not Optionable
Beta
0.06

Social Links

10 Best Cheap Stocks to Buy Now Cover
10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Robert F. Bartlett (Age 78)
    Pres, CEO & Director
  • Mr. Mark Stuart Elliott (Age 48)
    VP of Fin. and Principal Financial & Accounting Officer
    Comp: $162k
  • Dr. Zhinong Yan
    Exec. VP of Technology & Bus. Devel.
  • Mr. John Kasperski
    VP of Sales

Key Competitors

View All Competitors













PURE Stock - Frequently Asked Questions

How have PURE shares performed in 2023?

PURE Bioscience's stock was trading at $0.0848 at the beginning of the year. Since then, PURE shares have increased by 25.3% and is now trading at $0.1063.
View the best growth stocks for 2023 here.

Are investors shorting PURE Bioscience?

PURE Bioscience saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 19,700 shares, a decrease of 36.9% from the August 15th total of 31,200 shares. Based on an average daily trading volume, of 54,100 shares, the short-interest ratio is presently 0.4 days.
View PURE Bioscience's Short Interest.

When is PURE Bioscience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023.
View our PURE earnings forecast.

How were PURE Bioscience's earnings last quarter?

PURE Bioscience, Inc. (OTCMKTS:PURE) posted its quarterly earnings results on Thursday, March, 12th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.35 million for the quarter. PURE Bioscience had a negative net margin of 247.89% and a negative trailing twelve-month return on equity of 151.03%.

What other stocks do shareholders of PURE Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PURE Bioscience investors own include NVIDIA (NVDA), Boeing (BA), Overstock.com (OSTK), Pure Storage (PSTG), Riot Platforms (RIOT), Enphase Energy (ENPH), Mastercard (MA), Main Street Capital (MAIN), Twilio (TWLO) and

What is PURE Bioscience's stock symbol?

PURE Bioscience trades on the OTCMKTS under the ticker symbol "PURE."

How do I buy shares of PURE Bioscience?

Shares of PURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PURE Bioscience's stock price today?

One share of PURE stock can currently be purchased for approximately $0.11.

How much money does PURE Bioscience make?

PURE Bioscience (OTCMKTS:PURE) has a market capitalization of $11.89 million and generates $1.81 million in revenue each year. The company earns $-3,490,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis.

How can I contact PURE Bioscience?

PURE Bioscience's mailing address is 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA, 91730. The official website for the company is www.purebio.com. The company can be reached via phone at (619) 596-8600, via email at melliott@purebio.com, or via fax at 619-596-8790.

This page (OTCMKTS:PURE) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -